A kinome-wide RNAi screen identifies ERK2 as a druggable regulator of Shank3 stability
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A kinome-wide RNAi screen identifies ERK2 as a druggable regulator of Shank3 stability
Authors
Keywords
-
Journal
MOLECULAR PSYCHIATRY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-01-29
DOI
10.1038/s41380-018-0325-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An RNA interference screen identifies druggable regulators of MeCP2 stability
- (2017) Laura M. Lombardi et al. Science Translational Medicine
- Adult restoration of Shank3 expression rescues selective autistic-like phenotypes
- (2016) Yuan Mei et al. NATURE
- Reduction of Nuak1 Decreases Tau and Reverses Phenotypes in a Tauopathy Mouse Model
- (2016) Cristian A. Lasagna-Reeves et al. NEURON
- CLK2 inhibition ameliorates autistic features associated with SHANK3 deficiency
- (2016) Michael Bidinosti et al. SCIENCE
- Autism-associated SHANK3 haploinsufficiency causes Ih channelopathy in human neurons
- (2016) F. Yi et al. SCIENCE
- TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau
- (2016) Maxime WC Rousseaux et al. eLife
- TAF1 Variants Are Associated with Dysmorphic Features, Intellectual Disability, and Neurological Manifestations
- (2015) Jason A. O’Rawe et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Pumilio1 Haploinsufficiency Leads to SCA1-like Neurodegeneration by Increasing Wild-Type Ataxin1 Levels
- (2015) Vincenzo A. Gennarino et al. CELL
- Post-transcriptional regulation of SHANK3 expression by microRNAs related to multiple neuropsychiatric disorders
- (2015) Su-Yeon Choi et al. Molecular Brain
- Synaptic, transcriptional and chromatin genes disrupted in autism
- (2014) Silvia De Rubeis et al. NATURE
- The contribution of de novo coding mutations to autism spectrum disorder
- (2014) Ivan Iossifov et al. NATURE
- Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: A Gradient of Severity in Cognitive Impairments
- (2014) Claire S. Leblond et al. PLoS Genetics
- Transcriptional and functional complexity of Shank3 provides a molecular framework to understand the phenotypic heterogeneity of SHANK3 causing autism and Shank3 mutant mice
- (2014) Xiaoming Wang et al. Molecular Autism
- Epigenetic dysregulation of SHANK3 in brain tissues from individuals with autism spectrum disorders
- (2013) Li Zhu et al. HUMAN MOLECULAR GENETICS
- Shank3 Deficiency Induces NMDA Receptor Hypofunction via an Actin-Dependent Mechanism
- (2013) L. J. Duffney et al. JOURNAL OF NEUROSCIENCE
- SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties
- (2013) Kihoon Han et al. NATURE
- RAS–MAPK–MSK1 pathway modulates ataxin 1 protein levels and toxicity in SCA1
- (2013) Jeehye Park et al. NATURE
- SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients
- (2013) Aleksandr Shcheglovitov et al. NATURE
- Cutaneous side effects of inhibitors of the RAS/RAF/MEK/ERK signalling pathway and their management
- (2012) I. Manousaridis et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- GKAP orchestrates activity-dependent postsynaptic protein remodeling and homeostatic scaling
- (2012) Seung Min Shin et al. NATURE NEUROSCIENCE
- Importance of Shank3 Protein in Regulating Metabotropic Glutamate Receptor 5 (mGluR5) Expression and Signaling at Synapses
- (2011) Chiara Verpelli et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Skyline: an open source document editor for creating and analyzing targeted proteomics experiments
- (2010) Brendan MacLean et al. BIOINFORMATICS
- Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral MAPK/ERK Kinase Inhibitor PD-0325901 in Patients with Advanced Cancers
- (2010) P. M. LoRusso et al. CLINICAL CANCER RESEARCH
- Genome-wide YFP Fluorescence Complementation Screen Identifies New Regulators for Telomere Signaling in Human Cells
- (2010) Ok-Hee Lee et al. MOLECULAR & CELLULAR PROTEOMICS
- Regulated RalBP1 Binding to RalA and PSD-95 Controls AMPA Receptor Endocytosis and LTD
- (2009) Kihoon Han et al. PLOS BIOLOGY
- SCFβ-TRCP controls oncogenic transformation and neural differentiation through REST degradation
- (2008) Thomas F. Westbrook et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search